Premium
Deformability of transfused red blood cells is a potent effector of transfusion‐induced hemoglobin increment: A study with β‐thalassemia major patients
Author(s) -
Barshtein Gregory,
Goldschmidt Neta,
Pries Axel R,
Zelig Orly,
Arbell Dan,
Yedgar Saul
Publication year - 2017
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24821
Subject(s) - medicine , thalassemia , packed red blood cells , hemoglobin , anemia , blood transfusion , red blood cell , surgery , immunology
REFERENCES [1] Lanza F, Campioni DC, Hellmann A, et al. Quality Assessment of Haematopoietic Stem Cell Grafting Committee of European Blood and Marrow Transplantation Society. Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation. Biol Blood Marrow Transplant. 2013;19(12):1670–1676. [2] Niederwieser D, Schmitz S. Biosimilar agents in oncology/haematology: from approval to practice. Eur J Haematol. 2011;86:277e88. [3] Duong HK, Savani BN, Copelan E, et al. Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2014;20(9):1262–1273. [4] Lanza F, Lemoli RM, Olivieri A, et al. Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma. Transfusion. 2014;54 (2):331–339. Erratum in: Transfusion. 2014 Jun;54(6):1688–91. [5] Pezzi A, Cavo M, Biggeri A, et al. Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma. BMC Med Res Methodol. 2016;16(1):150 [6] Cesaro S, Tridello G, Prete A, et al. Biosimilar granulocyte colony stimulating factor for mobilization of autologous peripheral blood stem cell in pediatric hematology-oncology patients. Transfusion. 2015;55(2):246–252.